N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study

Background: Multiple Sclerosis (MS) is an autoimmune disease marked by progressive neurocognitive injury. Treatment options affording neuroprotective effects remain largely experimental. The purpose of this proof of concept study was to explore the effects of N-acetyl-cysteine (NAC) on cerebral gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Monti, Daniel A., Zabrecky, George, Leist, Thomas P., Wintering, Nancy, Bazzan, Anthony J., Zhan, Tingting, Newberg, Andrew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033492/
https://www.ncbi.nlm.nih.gov/pubmed/32117038
http://dx.doi.org/10.3389/fneur.2020.00088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033492/
https://www.ncbi.nlm.nih.gov/pubmed/32117038
http://dx.doi.org/10.3389/fneur.2020.00088

Ejemplares similares